Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 4
1936 2
1937 1
1945 1
1975 1
1980 1
1981 1
1984 1
1998 1
2000 1
2003 1
2004 2
2005 3
2006 6
2007 3
2008 14
2009 14
2010 11
2011 8
2012 12
2013 13
2014 13
2015 15
2016 23
2017 14
2018 20
2019 14
2020 18
2021 24
2022 12
2023 10
2024 11
2025 14
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Results by year

Filters applied: . Clear all
Page 1
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.
Tai YT, Mayes PA, Acharya C, Zhong MY, Cea M, Cagnetta A, Craigen J, Yates J, Gliddon L, Fieles W, Hoang B, Tunstead J, Christie AL, Kung AL, Richardson P, Munshi NC, Anderson KC. Tai YT, et al. Among authors: acharya c. Blood. 2014 May 15;123(20):3128-38. doi: 10.1182/blood-2013-10-535088. Epub 2014 Feb 25. Blood. 2014. PMID: 24569262 Free PMC article.
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.
Pilcher WC, Yao L, Gonzalez-Kozlova E, Pita-Juarez Y, Karagkouni D, Acharya CR, Michaud ME, Hamilton M, Nanda S, Song Y, Sato K, Wang JT, Satpathy S, Ma Y, Schulman J, D'Souza D, Jayasinghe RG, Ohlstrom D, Ferguson KE, Cheloni G, Bakhtiari M, Pabustan N, Nie K, Foltz JA, Saldarriaga I, Alaaeldin R, Lepisto E, Chen R, Fiala MA, Thomas BE, Cook A, Santos JVD, I-Ling C, Figueiredo I, Fortier J, Slade M, Oh ST, Rettig MP, Anderson E, Li Y, Dasari S, Strausbauch MA, Simon VA; Immune Atlas Consortium; Radkevich E, Rahman AH, Chen Z, Lagana A, DiPersio JF, Rosenblatt J, Kim-Schulze S, Lonial S, Kumar S, Bhasin SS, Kourelis T, Dhodapkar MV, Vij R, Avigan D, Cho HJ, Mulligan G, Ding L, Gnjatic S, Vlachos IS, Bhasin M. Pilcher WC, et al. Among authors: acharya cr. Nat Cancer. 2026 Jan;7(1):224-246. doi: 10.1038/s43018-025-01072-4. Epub 2026 Jan 9. Nat Cancer. 2026. PMID: 41514053 Free PMC article.
Current Management of Hepatic Encephalopathy.
Acharya C, Bajaj JS. Acharya C, et al. Am J Gastroenterol. 2018 Nov;113(11):1600-1612. doi: 10.1038/s41395-018-0179-4. Am J Gastroenterol. 2018. PMID: 30002466 Review. No abstract available.
Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma.
Ohlstrom DJ, Pilcher WC Jr, Michaud ME, Acharya C, Satpathy S, Gonzalez-Kozlova E, Jayasinghe RG, Ferguson K, Mumme HL, Nanda S, Song Y, Mantrala S, Karagkouni D, Schulman J, Pabustan N, Vieira Dos Santos J, Sherbenou DW, Keats JJ, Gout AM, Foltz S, Lagana A, Kourelis T, Vij R, Dhodapkar MV, Avigan D, Cho HJ, Baughn LB, Nooka AK, Lonial S, Kumar S, Samur MK, Vlachos IS, Ding L, Gnjatic S, Mulligan G, Bhasin MK. Ohlstrom DJ, et al. Among authors: acharya c. Blood Cancer Discov. 2026 Mar 4;7(2):266-286. doi: 10.1158/2643-3230.BCD-25-0205. Blood Cancer Discov. 2026. PMID: 41364805 Free PMC article.
Response to Labenz and Labenz.
Acharya C, Bajaj JS. Acharya C, et al. Am J Gastroenterol. 2021 Nov 1;116(11):2304. doi: 10.14309/ajg.0000000000001406. Am J Gastroenterol. 2021. PMID: 34404082 No abstract available.
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.
Pilcher WC, Yao L, Gonzalez-Kozlova E, Pita-Juarez Y, Karagkouni D, Acharya CR, Michaud ME, Hamilton M, Nanda S, Song Y, Sato K, Wang JT, Satpathy S, Ma Y, Schulman J, D'Souza D, Jayasinghe RG, Cheloni G, Bakhtiari M, Pabustan N, Nie K, Foltz JA, Saldarriaga I, Alaaeldin R, Lepisto E, Chen R, Fiala MA, Thomas BE, Cook A, Dos Santos JV, Chiang IL, Figueiredo I, Fortier J, Slade M, Oh ST, Rettig MP, Anderson E, Li Y, Dasari S, Strausbauch MA, Simon VA; Immune Atlas Consortium; Rahman AH, Chen Z, Lagana A, DiPersio JF, Rosenblatt J, Kim-Schulze S, Dhodapkar MV, Lonial S, Kumar S, Bhasin SS, Kourelis T, Vij R, Avigan D, Cho HJ, Mulligan G, Ding L, Gnjatic S, Vlachos IS, Bhasin M. Pilcher WC, et al. Among authors: acharya cr. bioRxiv [Preprint]. 2024 May 17:2024.05.15.593193. doi: 10.1101/2024.05.15.593193. bioRxiv. 2024. Update in: Nat Cancer. 2026 Jan;7(1):224-246. doi: 10.1038/s43018-025-01072-4. PMID: 38798338 Free PMC article. Updated. Preprint.
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes.
Elsaid MI, Li N, Firkins SA, Rustgi VK, Paskett ED, Acharya C, Reddy KR, Chiang CW, Mumtaz K. Elsaid MI, et al. Among authors: acharya c. Aliment Pharmacol Ther. 2024 May;59(9):1096-1110. doi: 10.1111/apt.17925. Epub 2024 Mar 27. Aliment Pharmacol Ther. 2024. PMID: 38538967
258 results